Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.99B |
| 2 |
Apple
AAPL
|
+$2.23B |
| 3 |
NVIDIA
NVDA
|
+$1.92B |
| 4 |
Amazon
AMZN
|
+$1.75B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altair Engineering Inc
ALTR
|
+$152M |
| 2 |
Merck
MRK
|
+$142M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$141M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$132M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 11.04% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Lineage Cell Therapeutics
LCTX
$278M
| $2.03M | ﹤0.01% |
4,485,586
+795,100
| +22% | +$466K |
|
3027
Wheels Up
UP
$198M
| $2.03M | ﹤0.01% |
100,264
+1,331
| +1% | +$36.7K |
|
|
MBX
3028
MBX Biosciences
MBX
$3.27B
| $2.03M | ﹤0.01% |
274,458
+8,755
| +3% | +$92.6K |
|
3029
Hawthorn Bancshares
HWBK
$278M
| $2.02M | ﹤0.01% |
71,434
+2,972
| +4% | +$91.2K |
|
3030
Prairie Operating Co
PROP
$78.1M
| $2.01M | ﹤0.01% |
375,456
+124,842
| +50% | +$911K |
|
3031
Western New England Bancorp
WNEB
$275M
| $1.98M | ﹤0.01% |
213,271
+6,938
| +3% | +$64K |
|
3032
First United
FUNC
$289M
| $1.98M | ﹤0.01% |
65,907
+2,507
| +4% | +$84.5K |
|
3033
Neumora Therapeutics
NMRA
$302M
| $1.98M | ﹤0.01% |
1,976,302
+6,022
| +0.3% | +$10.3K |
|
|
ADVM
3034
DELISTED
Adverum Biotechnologies
ADVM
| $1.97M | ﹤0.01% |
451,258
+8,768
| +2% | +$39.5K |
|
3035
AudioEye
AEYE
$75M
| $1.97M | ﹤0.01% |
177,291
+18,224
| +11% | +$275K |
|
3036
Torrid Holdings
CURV
$260M
| $1.97M | ﹤0.01% |
359,171
+11,363
| +3% | +$68.1K |
|
3037
Bilibili
BILI
$7.84B
| $1.97M | ﹤0.01% |
102,953
-7,607
| -7% | -$146K |
|
3038
Virgin Galactic
SPCE
$398M
| $1.97M | ﹤0.01% |
648,249
+42,887
| +7% | +$188K |
|
3039
Solid Biosciences
SLDB
$900M
| $1.96M | ﹤0.01% |
530,859
+21,057
| +4% | +$90.2K |
|
|
IRBT
3040
DELISTED
iRobot
IRBT
| $1.96M | ﹤0.01% |
724,296
+23,123
| +3% | +$167K |
|
3041
Larimar Therapeutics
LRMR
$432M
| $1.95M | ﹤0.01% |
907,961
+21,547
| +2% | +$68.1K |
|
3042
Northern Technologies International Corp
NTIC
$80M
| $1.95M | ﹤0.01% |
187,534
+10,775
| +6% | +$126K |
|
3043
First Community Corp
FCCO
$322M
| $1.94M | ﹤0.01% |
85,925
+3,033
| +4% | +$73.9K |
|
3044
1stdibs.com
DIBS
$171M
| $1.93M | ﹤0.01% |
636,134
-12,180
| -2% | -$43.7K |
|
3045
First National Corp
FXNC
$287M
| $1.93M | ﹤0.01% |
85,998
-493
| -0.6% | -$11.8K |
|
|
PSIX
3046
Power Solutions International
PSIX
$942M
| $1.93M | ﹤0.01% |
+76,349
| New | +$2.63M |
|
3047
Ericsson
ERIC
$33.3B
| $1.93M | ﹤0.01% |
248,731
-49,203
| -17% | -$397K |
|
3048
iQIYI
IQ
$1.28B
| $1.93M | ﹤0.01% |
852,536
-14,747
| -2% | -$32.4K |
|
3049
Sight Sciences
SGHT
$412M
| $1.93M | ﹤0.01% |
801,985
+9,125
| +1% | +$25.7K |
|
|
VNET
3050
VNET Group
VNET
$2.09B
| $1.92M | ﹤0.01% |
234,475
-39,587
| -14% | -$363K |
|
Similar funds
Geode Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Geode Capital Management held 4,591 positions worth $1.27T, down 1.4% from $1.29T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Geode Capital Management deployed $47.9B of net new capital in Q1 2025, opening 122 new positions and adding to 3,780 existing holdings. Its largest new stake was Sandisk: 1,936,245 shares worth $92.2M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $142M trimmed.
- Geode Capital Management's largest Q1 2025 buy was Sandisk: 1,936,245 shares worth $92.2M.
- Geode Capital Management added most to Microsoft in Q1 2025, an estimated $2.99B increase.
- Geode Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $142M.
- Geode Capital Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $152M.
- Geode Capital Management's ten largest holdings make up 29% of its $1.27T portfolio in Q1 2025.
- Geode Capital Management opened 122 new positions and closed 115 in Q1 2025.
- Geode Capital Management's portfolio value fell 1.4% quarter-over-quarter to $1.27T.
Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.